Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
about
The treatment of Parkinson's disease with deep brain stimulation: current issuesThe hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Continuous drug delivery in Parkinson's disease.Behavioral effects of levodopa.Parkinson's Disease and Its Management: Part 4: Treatment of Motor ComplicationsLevodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsThe role of subcutaneous infusion of apomorphine in Parkinson's disease.Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.New treatments for levodopa-induced motor complications.A review of current and novel levodopa formulations for the treatment of Parkinson's disease.Algorithms for the treatment of motor problems in Parkinson's disease.The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel.Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.Exploring Issues Around Wearing-off and Quality of Life: The OFF-PARK Survey of People with Parkinson's Disease and their Care Partners.Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS).Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.Observational study of quality of life of Parkinson's patients and their caregivers.Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.Extended-release oral capsule of carbidopa-levodopa in Parkinson disease.The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
P2860
Q26786762-1637601C-00CD-4A3A-9098-451DD4EBE65AQ30248922-68460C55-4D7B-4EC2-BDED-F5895AB45494Q34390800-7C972362-3706-49AD-9FA1-8CE0AA1CD444Q34452922-3B61C387-7EB6-4264-A5A9-D9D37C18565AQ36251899-17703955-61DE-48F7-AE1D-14593F9A3A00Q36361513-94F133BC-EF3E-4EC8-92F7-16F207A3C880Q38219351-5FB522C2-36B0-49B7-B587-3AE7BDFE66DAQ38242043-51345CFC-C65D-498F-8943-A53639F95B2CQ38314257-70E039AE-A2F9-47CF-979D-45E97C6EC285Q38530328-A683A3B2-C5AD-46A8-8233-990251FEE17AQ38570434-444DF684-DD11-4EC5-8E8B-95C812A499EBQ38740274-0905B089-A626-47C8-BFFC-2FCE48F9C6F6Q38992788-60A1F0CA-C465-4676-8CCC-4350E2FD4CAEQ39099746-11EF4BF7-FE36-40DB-B1B6-4D8E373E4A56Q39578837-7A5B9B7A-DE06-442B-BF95-74A78F8B3331Q39773537-58B03696-E0D0-4070-9F15-C60C6A3FC6CCQ40501932-DF044CC0-E6BD-4B81-8DC2-75930B0A0E4DQ46895728-25205786-9C1E-4DC4-8863-F4E3A0EBC652Q47120831-F862E9CF-EE0D-4337-B4A6-B668C1C54F51Q47716445-C7B7FB5F-6585-44D4-97EE-6CF27C3800D2Q48128791-79CAEBCF-3635-4BFE-8927-A79322950678Q48425550-C17DFCB9-3A5F-4AD4-A23C-719A4D9639C7Q49335971-B5DB1D24-5B94-4184-BCEE-EEAA86B69845Q52316533-6D33603A-620E-4396-A57D-196FD229F435Q59125833-922B6458-D51B-4BFE-9BDC-939118A2E0B4
P2860
Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Motor and nonmotor complicatio ...... for continuous drug delivery?
@en
Motor and nonmotor complicatio ...... for continuous drug delivery?
@nl
type
label
Motor and nonmotor complicatio ...... for continuous drug delivery?
@en
Motor and nonmotor complicatio ...... for continuous drug delivery?
@nl
prefLabel
Motor and nonmotor complicatio ...... for continuous drug delivery?
@en
Motor and nonmotor complicatio ...... for continuous drug delivery?
@nl
P2860
P1476
Motor and nonmotor complicatio ...... for continuous drug delivery?
@en
P2093
Alexandra Rizos
Kapil D Sethi
P2860
P2888
P304
P356
10.1007/S00702-013-0981-5
P577
2013-03-02T00:00:00Z
2013-09-01T00:00:00Z